Neglected Tropical Diseases Diagnosis Market Prominent Players, Competitive Landscape & Business Opportunities, 2025

Felton, Calif., USA, Jan. 27, 2021 — /EPR Network/ —

The global Neglected Tropical Diseases Diagnosis Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

The global Neglected Tropical Diseases Diagnosis market is expected to reach $7.6 Billion by 2025 with CAGR of 4.1% in the forthcoming period. The market is driven by factors such as huge attention paid to by healthcare organizations; which, in turn, acts as a booster for funding R&D and treatment. Healthcare facilities, immediate medical attention, and highly skilled medical professionals are expected to contribute to the global market growth.

Key Players:

  • Hoffmann-La Roche Ltd
  • Abbott
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix
  • InBios International, Inc.
  • Genome Diagnostics Pvt. Ltd.
  • Omega Diagnostics Group PLC
  • Coris Bioconcept SPRL

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/neglected-tropical-diseases-diagnosis-market/request-sample

Growth Drivers:

The market witnesses several opportunities in form of rise in number of NGOs, increasing R&D activities, and availability of large patient pool. However, restraints such as low medical attention, non-availability of medicines and resources, and dearth of medical professionals in extreme regions are likely to create hindrance in the Neglected Tropical Diseases Diagnosis market upto 2025.

Diagnostic Method Outlook:

  • Conventional Method
  • Molecular/Modern Method

Service Type Outlook:

  • Centralized Service
  • POC Service

End-use Outlook:

  • Clinical Labs
  • Hospitals /Clinics
  • Home Healthcare

Regional Outlook:

South American market is expected to grow at a rapid pace in the forthcoming period due to reasons such as favorable opportunities and increasing awareness among the population. Rise in R&D activities and ways to deal with NTDs is likely to create favorable market conditions in the APAC sector. Tropical regions such as Africa account for a higher growth in the forecast period due to growing tribal population, moderate healthcare infrastructure, and uncontrolled birth rates. Other reasons such as lack of social hygiene, delay of medical attention, animal bite, and extreme climate is likely to contribute to the African Neglected Tropical Diseases Diagnosis market. However, medical NGOs and activists are trying ways to tackle medical problems in Africa; subsequently boosting the health awareness against NTDs among the population.

North American Neglected Tropical Disease Diagnosis market is likely to gain a moderate CAGR in the forecast period due to advanced medical infrastructure, improved health conditions, and favorable reimbursement. APAC sector is likely to gain a highly moderate CAGR owing to imbalanced health conditions caused by underlying healthcare facilities in various regions. India, Vietnam, South Korea, and China are likely to gain a popular share owing to rise in number of medical NGOs to solve NTD issues, also rise in healthcare infrastructure and medical attention are some factors that nourish the Neglected Tropical Diseases Diagnosis Industry growth.

Browse Related Category Research Reports @ https://blog.naver.com/tomclark

Matched content

Editor’s pick

Express Press Release Distribution